BriaCell Therapeutics Stock (NASDAQ: BCTX) stock price, news, charts, stock research, profile.
|Vol / Avg.79.281K / 91.899K||Mkt Cap76.073M|
|Day Range4.640 - 4.970||52 Wk Range3.670 - 8.100|
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|2023-10-03||HC Wainwright & Co.||Emily Bodnar||Maintains||BuyBuy||Lowers||25.00||20.00|
|2023-06-28||HC Wainwright & Co.||Emily Bodnar||Reiterates||BuyBuy||Maintains||-||25.00|
|2023-02-24||HC Wainwright & Co.||Emily Bodnar||Reiterates||Buy||Maintains||-||25.00|
|2022-02-14||HC Wainwright & Co.||Emily Bodnar||Initiates Coverage On||Buy||Announces||-||25.00|
You can purchase shares of BriaCell Therapeutics (NASDAQ: BCTX) through any online brokerage.
There are no as such competitors for BriaCell Therapeutics.
The latest price target for BriaCell Therapeutics (NASDAQ: BCTX) was reported by HC Wainwright & Co. on Tuesday, October 3, 2023. The analyst firm set a price target for 20.00 expecting BCTX to rise to within 12 months (a possible 320.17% upside). 3 analyst firms have reported ratings in the last year.
The stock price for BriaCell Therapeutics (NASDAQ: BCTX) is $4.76 last updated December 8, 2023 at 9:00 PM UTC.
There is no dividend information for BriaCell Therapeutics.
BriaCell Therapeutics’s Q1 earnings are confirmed for Friday, December 22, 2023.
There is no upcoming split for BriaCell Therapeutics.
BriaCell Therapeutics is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.